Evolus Inc risk profile

51 Elevated one input has moved against it

Measured 1 September 2026 from EOLS's filed statements. Recomputed nightly.

51 (Elevated), driven by Cash conversion at 100, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation45ElevatedVolatileOne-year price volatility — 66.5%
Operating pressure19ContainedWorseningCosts outgrowing revenue — +2.2 percentage points
Cash conversion100AcuteWorseningCapital spending against operating cash — -0.08x
Leverage and coverage88AcuteStableNet debt to EBITDA
Competitive position44ElevatedStableOperating-margin gap against peers — -0.7 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Evolus Inc